Sheila A Fisher, Antony Cutler, Carolyn Doree, Susan J Brunskill, Simon J Stanworth: Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. In: Cochrane Database of Systematic Reviews. 30. Januar 2019, doi:10.1002/14651858.CD009768.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F Murphy: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. In: Cochrane Database of Systematic Reviews. 16. Mai 2012, doi:10.1002/14651858.CD004269.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
Lise J Estcourt, Simon J Stanworth, Carolyn Doree, Sally Hopewell, Marialena Trivella: Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In: Cochrane Database of Systematic Reviews. 18. November 2015, doi:10.1002/14651858.CD010983.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
Linus Knips, Nils Bergenthal, Fiona Streckmann, Ina Monsef, Thomas Elter: Aerobic physical exercise for adult patients with haematological malignancies. In: Cochrane Database of Systematic Reviews. 31. Januar 2019, doi:10.1002/14651858.CD009075.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
haematologica.org
online.haematologica.org
L. Degos: John Hughes Bennett, Rudolph Virchow … and Alfred Donné: the first description of leukemia. In: The Hematology Journal. (2001) 2, S. 1. Volltext
M. C. Bene u. a.: Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). In: Leukemia. 1995;9(10), S. 1783–1786. PMID 7564526
M. W. Jansen u. a.: Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. In: Leukemia. 2007; 21, S. 633–641. PMID 17268512
E. Forestier u. a.: Cytogenetic findings in a population-based series of 787 childhood acute lymphoblastic leukemias from the Nordic countries. The NOPHO Leukemia Cytogenetic Study Group. In: Eur J Haematol. 2000; 64(3), S. 194–200. PMID 10997816
M. L. Loh u. a.: Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95–01. In: Blood. 2006; 107(11), S. 4508–4513. PMID 16493009
J. M. Ribera u. a.: Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. In: Haematologica. 2002; 87(2), S. 154–166. PMID 11836166
A. Möricke u. a.: Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95. In: Klin Padiatr. 2005; 217, S. 310–320. PMID 16307416
D. M. Loo u. a.: Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. In: J Clin Oncol. 2006; 24(15), S. 2332–2336. PMID 16710032
M. Clarke u. a.: CNS-directed therapy for childhood acute lymphoblastic leukemia: Childhood ALL Collaborative Group overview of 43 randomized trials. In: J Clin Oncol. 2003; 21(9), S. 1798–1809. PMID 12721257.
J. M. Goldberg u. a.: Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. In: J Clin Oncol. 2003;21(19), S. 3616–3622. PMID 14512392.
G. M. Marshall u. a.: Importance of minimal residual disease testing during the second year of therapy for children with acute lymphoblastic leukemia.J Clin Oncol. 2003; 21(4), S. 704–709. PMID 12586809
C. Nyvold u. a.: Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. In: Blood. 2002; 99(4), S. 1253–1258. PMID 11830473
M. Brüggemann u. a.: Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. In: Blood. 2006;107(3), S. 1116–1123. PMID 16195338
T. Raff u. a.: Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment: data from the GMALL 06/99 and 07/03 trials. In: Blood. 2007;109(3), S. 910–915. PMID 17023577
D. O. Harms u. a.: Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92. In: Blood. 2003; 102(8), S. 2736–2740. PMID 12843002
T. Langer u. a.: CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. In: Med Pediatr Oncol. 2002; 38(5), S. 320–328. PMID 11979456
J. H. Laver u. a.: Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report.PMID 10720128
V. Conter u. a.: Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups. In: Leukemia. 2000;14(3), S. 369–373. In: J Clin Oncol. 1997;15(8), S. 2786–2791. PMID 9256120
Sheila A Fisher, Antony Cutler, Carolyn Doree, Susan J Brunskill, Simon J Stanworth: Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. In: Cochrane Database of Systematic Reviews. 30. Januar 2019, doi:10.1002/14651858.CD009768.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
Lise Estcourt, Simon Stanworth, Carolyn Doree, Sally Hopewell, Michael F Murphy: Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. In: Cochrane Database of Systematic Reviews. 16. Mai 2012, doi:10.1002/14651858.CD004269.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
Lise J Estcourt, Simon J Stanworth, Carolyn Doree, Sally Hopewell, Marialena Trivella: Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. In: Cochrane Database of Systematic Reviews. 18. November 2015, doi:10.1002/14651858.CD010983.pub2 (wiley.com [abgerufen am 9. Juli 2020]).
Linus Knips, Nils Bergenthal, Fiona Streckmann, Ina Monsef, Thomas Elter: Aerobic physical exercise for adult patients with haematological malignancies. In: Cochrane Database of Systematic Reviews. 31. Januar 2019, doi:10.1002/14651858.CD009075.pub3 (wiley.com [abgerufen am 9. Juli 2020]).
